Barron’s writer Ben Levisohn discusses the opportunities and risks in crude’s recent slide.
Tag: Ben Levisohn
VIDEO: Why LSB Industries Could Double
Tough times for pharma stock Theravance, a boost for a mini-congolerate, and better news ahead for CIT.